9-fluoro-10-(N-(4'-methyl)piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido(1,2,3de)-1,4-benzothiazine-6-carboxylic acid,
MF 934,
MF-934,
rufloxacin,
rufloxacin hydrobromide,
rufloxacin hydrochloride,
rufloxacin monohydrobromide,
rufloxacin monohydrochloride,
RUFLOXACIN HYDROCHLORIDE,
106017-08-7,
MF-934,
UNII-1643374N6L,
9-fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride,
1643374N6L,
DSSTox_CID_25709,
DSSTox_RID_81081,
DSSTox_GSID_45709,
7H-Pyrido[1,2,3-de]-1,4-benzothiazine-6-carboxylicacid, 9-fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrochloride(1:1),
Rufloxacin hydrochloried,
2,3-Dihydro-9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acid hydrochloride;2,3-Dihydro-9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acid hydrochloride,
7H-Pyrido(1,2,3-de)(1,4)benzothiazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-, monohydrochloride,
CAS-106017-08-7,
NCGC00074024-02,
Rufloxacin (hydrochloride),
monose,
Tebraxin,
Monos,
Qari,
Qari (TN),
ACMC-20ek5c,
Rufloxacin(hydrochloride),
AC1L41VB,
SCHEMBL51616,
C17H18FN3O3S.HCl,
MLS000041115,
CHEMBL1385206,
DTXSID0045709,
CTK0H5111,
HY-B0902A,
BCP13481,
Tox21_110990,
ISF-09334,
MFCD00912283,
AKOS015913984,
Tox21_110990_1,
API0004112,
H63R104,
MCULE-3553789906,
KS-00001F99,
NCGC00074024-03,
AC-18051,
AN-33890,
CPD000046069,
SAM001246726,
SMR000046069,
LS-133186,
RT-015465,
FT-0631036,
D08496,
C-21708,
J-001520,
I14-44761,
2,3-Dihydro-9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acid hydrochloride,
7-fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.0^{5,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;hydrochloride,
9-Fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid (HCl),
C17H18FN3O3S.ClH,
CID176015,
CS-4368,
C17-H18-F-N3-O3-S.Cl-H,